Skip to main content
. 2022 Sep 29;18(2):372–379. doi: 10.1177/19322968221128565

Table 2.

24-h Glucose Control During OL and CL Periods in Patients Exhibiting ≥ 5% of Time in Low Glucose.

WP7 (n = 9) WP8 (n = 28) WP9 (n = 8) Total (n = 45)
OL CL OL CL OL CL OL CL
Diff CL-OL
P value
size effect
Diff CL-OL
P value
size effect
Diff CL-OL
P value
size effect
Diff CL-OL
P value
size effect
Time in low glucose (54 to <70 mg/dL) (%)
8.3 ± 2.3 3.3 ± 1.6 7.9 ± 2.5 3.1 ± 1.7 7.4 ± 2.1 3.5 ± 1.7 7.9 ± 2.4 3.2 ± 1.6
−5.9 [−6.8, −3.1]
0.0003
2.1
−4.9 [−5.6, −4.0]
<10−4
2.1
−4.0 [−5.3, −2.7]
0.0002
1.7
−4.7 [−5.3, −4.1]
<10−4
2.2
Time in very low glucose (<54 mg/dL) (%)
2.1 ± 1.1 0.8 ± 0.5 1.9 ± 1.5 0.7 ± 0.8 1.6 ± 0.9 0.9 ± 0.6 1.9 ± 1.3 0.8 ± 0.7
−1.3 [−2.1, −0.5]
0.0044
1.3
−0.9 [−1.6, −0.8]
<10-4
0.9
−0.6 [−1.1, −0.3]
0.0047
0.8
−0.9 [−1.4, −0.8]
<10−4
1.0
Time in range (70-180 mg/dL) (%)
65.4 ± 9.4 72.0 ± 10.6 62.5 ± 10.3 67.4 ± 8.2 63.6 ± 6.8 66.8 ± 3.8 63.3 ± 9.5 68.2 ± 8.2
6 [2.4, 10.7]
0.0066
0.5
4.7 [1.8, 8.0]
0.0028
0.5
0.2 [−0.7, 7.1]
0.0944
0.5
5.1 [2.9, 7.0]
<10−4
0.5
Time in high glucose (>180 mg/dL) (%)
26.3 ± 10.1 24.7 ± 10.8 29.6 ± 10.6 29.5 ± 7.9 29 ± 7.7 29.8 ± 3.6 28.8 ± 9.9 28.6 ± 8.1
0.4 [−5.8, 2.7]
0.417
0.1
−0.3 [−3.2, 3]
0.955
0.0
0.5 [−4.2, 5.7]
0.773
0.1
−0.2 [−2.4, 1.9]
0.827
0.0
Time in very high glucose (>250 mg/dL) (%)
7.7 ± 5 6.3 ± 4.8 9.7 ± 5.9 8.5 ± 4.6 10.5 ± 5.2 8.4 ± 3.1 9.4 ± 5.6 8 ± 4.4
−1.2 [−3.6, 0.9]
0.196
0.2
−0.7 [−3, 0.7]
0.204
0.2
−2.7 [−5.2, 1.1]
0.161
0.4
−1.1[−2.6, −0.1]
0.035
0.3
Glycemia Risk Index
48.8 ±10.9 33.7 ± 12.5 52.0 ± 13.9 38.8 ± 11.4 50.8 ± 9.0 39.9 ± 6.7 51.2 ± 12.4 38.0 ± 12.9
−15.3 [−21.0, −9.1]
0.0003
1.1
−12.6 [−17.3, −9.2]
<10−4
1.0
−11.0 [−15.4, −6.5]
0.0007
1.1
−13.1 [−16.0, −10.4]
<10−4
1.1

Data are given as mean (SD). Differences are shown as median [95% CI]. Paired t-test and Cohen’s d test are provided.

Abbreviation: OL, open loop; CL, closed loop; CI, confidence interval.